Cargando…

The Utilization of a New Immunochromatographic Test in Detection of Helicobacter pylori Antibody from Maternal and Umbilical Cord Serum

Background. Helicobacter pylori (H. pylori) was linked with several extragastrointestinal diseases, including preeclampsia and intrauterine growth restriction of fetus. One of the signals which can be transferred from mother to fetus is the H. pylori IgG antibody. Aims. We utilized a commercial immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Fu-Chen, Wu, Chien-Yi, Kuo, Chao-Hung, Wu, Chia-Fang, Lu, Chien-Yu, Chen, Yen-Hsu, Chen, Chiao-Yun, Lo, Yi-Ching, Wu, Ming-Tsang, Hu, Huang-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142160/ https://www.ncbi.nlm.nih.gov/pubmed/25177695 http://dx.doi.org/10.1155/2014/568410

Ejemplares similares

Effect of Di(2-ethylhexyl)phthalate on Helicobacter pylori-Induced Apoptosis in AGS Cells
por: Lin, Chuang-Hao, et al.
Publicado: (2013)

The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
por: Kuo, Chao-Hung, et al.
Publicado: (2012)

The Effect of Helicobacter pylori Eradication on the Levels of Essential Trace Elements
por: Wu, Meng-Chieh, et al.
Publicado: (2014)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Helicobacter pylori Infection and Anemia in Taiwanese Adults
por: Shih, Hsiang-Yao, et al.
Publicado: (2013)

Toward population specific and personalized treatment of Helicobacter pylori infection
por: Liou, Jyh-Ming, et al.
Publicado: (2018)

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
por: Tsai, Kun-Feng, et al.
Publicado: (2017)

First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus
por: Yao, Chih-Chien, et al.
Publicado: (2019)

The interplay between Helicobacter pylori and gastrointestinal microbiota
por: Chen, Chieh-Chang, et al.
Publicado: (2021)

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
por: Jheng, Guang-Hong, et al.
Publicado: (2015)

Association between Helicobacter pylori eradication and the risk of coronary heart diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2018)

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2015)

Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy
por: Liou, Jyh-Ming, et al.
Publicado: (2022)

The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2014)

Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population
por: Shih, Hsiang-Yao, et al.
Publicado: (2012)

Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
por: Hu, Huang-Ming, et al.
Publicado: (2009)

A Rapid and Accurate Method to Evaluate Helicobacter pylori Infection, Clarithromycin Resistance, and CYP2C19 Genotypes Simultaneously From Gastric Juice
por: Kuo, Chao-Hung, et al.
Publicado: (2016)

A community-based study on the association between Helicobacter pylori Infection and obesity
por: Chen, Li-Wei, et al.
Publicado: (2018)

The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2016)

Risk for Irritable Bowel Syndrome in Patients with Helicobacter Pylori Infection: A Nationwide Population-Based Study Cohort Study in Taiwan
por: Liang, Chia-Ming, et al.
Publicado: (2020)

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
por: Tai, Wei-Chen, et al.
Publicado: (2013)

Rescue therapy for refractory Helicobacter pylori infection: current status and future concepts
por: Wang, Song-Wei, et al.
Publicado: (2023)

The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based Study
por: Chen, Li-Wei, et al.
Publicado: (2016)

Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study
por: Chang, Yang-Pei, et al.
Publicado: (2013)

Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2019)

Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations
por: Lee, Yi-Chia, et al.
Publicado: (2016)

IL-22 Negatively Regulates Helicobacter pylori-Induced CCL20 Expression in Gastric Epithelial Cells
por: Chen, Jia-Perng, et al.
Publicado: (2014)

Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections
por: Kuo, Chia-Jung, et al.
Publicado: (2019)

Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study
por: Chen, Li-Wei, et al.
Publicado: (2015)

Diagnosis of Helicobacter pylori infection in the elderly using an immunochromatographic assay‐based stool antigen test
por: Han, Yingjie, et al.
Publicado: (2020)

Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2020)

Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2022)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
por: Hung, Kuo-Tung, et al.
Publicado: (2021)

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
por: Tai, Wei-Chen, et al.
Publicado: (2019)

Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum
por: Kuo, Yang-Che, et al.
Publicado: (2022)

Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
por: Lee, Yi-Chia, et al.
Publicado: (2013)

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

CT characteristics and clinical implications of acute type A aortic intramural hematoma
por: Yen, Hsu-Ting, et al.
Publicado: (2023)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7fjjdjlsrl3oqfd7mpr10eiii